SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Value Investing -- Ignore unavailable to you. Want to Upgrade?


To: Paul Senior who wrote (17060)5/13/2003 11:05:05 PM
From: Madharry  Read Replies (1) | Respond to of 78661
 
OT Millenium received a limited approval from the FDA for their drug Velcade. What is interesting is that the approval came 2 months early. Smarter people than I believe that this signals a shift in the FDA policy towards more timely approval for treatment of life threatening diseases. Should be good for the patient and also the drug companies!
Dont be surprised to see across the board movement tomorrow
in biotechs and pharma.